Key result
Tricuspid valve replacement with a bioprosthesis in patients with congenital heart disease remains an unsolved dilemma regarding long-term durability.
Why the study?
Does tricuspid valve replacement with a bioprosthesis have adequate durability in patients with congenital heart disease?
Population
51 patients affected by congenital heart disease who underwent tricuspid valve replacement with a…
Design
Editorial
Authors
Loading...
This editorial discusses the durability of bioprosthetic tricuspid valves in patients with congenital heart disease, highlighting an ongoing clinical dilemma.
Does tricuspid valve replacement with a bioprosthesis have adequate durability in patients with congenital heart disease?
This editorial discusses the durability of bioprosthetic tricuspid valves in patients with congenital heart disease, highlighting an ongoing clinical dilemma.
Garatti et al. (2017) studied this question. Tricuspid valve replacement with a bioprosthesis in patients with congenital heart disease remains an unsolved dilemma regarding long-term durability.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: